Gut dysbacteriosis and intestinal disease: mechanism and treatment.
Meng X, Zhang G, Cao H, Yu D, Fang X, de Vos WM, Wu H.
J Appl Microbiol. 2020 Oct;129(4):787-805. doi: 10.1111/jam.14661. Epub 2020 May 19.
Mechanisms and consequences of intestinal dysbiosis.
Weiss GA, Hennet T.
Cell Mol Life Sci. 2017 Aug;74(16):2959-2977. doi: 10.1007/s00018-017-2509-x. Epub 2017 Mar 28.
Introduction to the human gut microbiota.
Thursby E, Juge N.
Biochem J. 2017 May 16;474(11):1823-1836. doi: 10.1042/BCJ20160510.
The human gut microbiota: Metabolism and perspective in obesity.
Gomes AC, Hoffmann C, Mota JF.
Gut Microbes. 2018 Jul 4;9(4):308-325. doi: 10.1080/19490976.2018.1465157. Epub 2018 May 24.
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
Drossman DA, Hasler WL.
Gastroenterology. 2016 May;150(6):1257-61. doi: 10.1053/j.gastro.2016.03.035.
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S.
Clin Microbiol Rev. 2022 Jan 19;35(1):e0033820. doi: 10.1128/CMR.00338-20. Epub 2022 Jan 5.
Dysbiosis and the immune system.
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E.
Nat Rev Immunol. 2017 Apr;17(4):219-232. doi: 10.1038/nri.2017.7. Epub 2017 Mar 6.
The gut microbiome and hypertension.
O'Donnell JA, Zheng T, Meric G, Marques FZ.
Nat Rev Nephrol. 2023 Mar;19(3):153-167. doi: 10.1038/s41581-022-00654-0. Epub 2023 Jan 11.
The role of enteric dysbacteriosis and modulation of gut microbiota in the treatment of inflammatory bowel disease.
Niu W, Yang F, Fu Z, Dong Y, Zhang Z, Ju J.
Microb Pathog. 2022 Apr;165:105381. doi: 10.1016/j.micpath.2021.105381. Epub 2021 Dec 30.
Dysbiosis: from fiction to function.
Tiffany CR, Bäumler AJ.
Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G602-G608. doi: 10.1152/ajpgi.00230.2019. Epub 2019 Sep 11.
